Patent ID: 8835389

Claim:
A method of treating rheumatoid arthritis in a patient in need thereof comprising orally administering to a patient having rheumatoid arthritis a therapeutically effective amount of a calcitonin in free or salt form and a delivery agent for calcitonin, wherein the delivery agent is selected from the group consisting of N-(5-chlorosalicyloyl)-8-aminocaprylic acid (5-CNAC), N-(10-[2-hydroxybenzoly]amino)decanoic acid (SNAD), N-(8-[2-hydroxybenzoyl]amino)caprylic acid (SNAC) and pharmaceutically acceptable salts, hydrates and alcohol solvates thereof, wherein said calcitonin in free or salt form is provided to said patient in a dosage range of between 0.4 mg and 2.5 mg.